1. Home
  2. ENTA vs INVZ Comparison

ENTA vs INVZ Comparison

Compare ENTA & INVZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTA
  • INVZ
  • Stock Information
  • Founded
  • ENTA 1995
  • INVZ 2016
  • Country
  • ENTA United States
  • INVZ Israel
  • Employees
  • ENTA N/A
  • INVZ N/A
  • Industry
  • ENTA Biotechnology: Pharmaceutical Preparations
  • INVZ Auto Parts:O.E.M.
  • Sector
  • ENTA Health Care
  • INVZ Consumer Discretionary
  • Exchange
  • ENTA Nasdaq
  • INVZ Nasdaq
  • Market Cap
  • ENTA 154.0M
  • INVZ 144.1M
  • IPO Year
  • ENTA 2013
  • INVZ N/A
  • Fundamental
  • Price
  • ENTA $5.55
  • INVZ $0.92
  • Analyst Decision
  • ENTA Buy
  • INVZ Strong Buy
  • Analyst Count
  • ENTA 4
  • INVZ 5
  • Target Price
  • ENTA $17.25
  • INVZ $3.24
  • AVG Volume (30 Days)
  • ENTA 178.5K
  • INVZ 2.0M
  • Earning Date
  • ENTA 05-12-2025
  • INVZ 05-14-2025
  • Dividend Yield
  • ENTA N/A
  • INVZ N/A
  • EPS Growth
  • ENTA N/A
  • INVZ N/A
  • EPS
  • ENTA N/A
  • INVZ N/A
  • Revenue
  • ENTA $66,590,999.00
  • INVZ $24,268,000.00
  • Revenue This Year
  • ENTA N/A
  • INVZ $130.12
  • Revenue Next Year
  • ENTA N/A
  • INVZ $135.62
  • P/E Ratio
  • ENTA N/A
  • INVZ N/A
  • Revenue Growth
  • ENTA N/A
  • INVZ 16.25
  • 52 Week Low
  • ENTA $4.09
  • INVZ $0.45
  • 52 Week High
  • ENTA $17.24
  • INVZ $3.14
  • Technical
  • Relative Strength Index (RSI)
  • ENTA 51.08
  • INVZ 70.04
  • Support Level
  • ENTA $4.96
  • INVZ $0.70
  • Resistance Level
  • ENTA $6.23
  • INVZ $0.78
  • Average True Range (ATR)
  • ENTA 0.34
  • INVZ 0.05
  • MACD
  • ENTA 0.01
  • INVZ 0.02
  • Stochastic Oscillator
  • ENTA 46.46
  • INVZ 98.51

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

About INVZ Innoviz Technologies Ltd. Ordinary shares

Innoviz Technologies Ltd is a provider of solid-state LiDAR and perception solutions that feature technological breakthroughs across core components and bring enhanced vision and superior performance to enable safe autonomous driving at a mass scale. The company provides a complete and comprehensive solution for OEMs and Tier-1 partners that are developing and marketing autonomous driving vehicles to the passenger cars and other relevant markets, such as robotaxis, shuttles, delivery vehicles, buses and trucks and other industries that require 3-dimensional high resolution sensors. Company's solutions can enable safe autonomy for industries like logistics, drones, robotics, construction and other industrial applications, agriculture, smart city, smart infrastructure, security and mapping.

Share on Social Networks: